Strong Industry Recognition Magstim has recently been recognized as the Medical, Pharma and Healthcare Manufacturer of the Year at the Made in Wales Awards 2025, which enhances its credibility and visibility within the medical device market, creating opportunities for partnerships and procurement.

Innovative Product Launches The company has launched the Magstim Rapid TMS System and promotes its advanced capabilities for treating mental health conditions such as Major Depressive Disorder and OCD, indicating strong growth in transcranial magnetic stimulation solutions suitable for psychiatric clinics and research institutions.

Strategic Collaborations Partnerships with academic institutions like Cardiff University and international distributors like NeuroStim demonstrate Magstim’s focus on collaborative research and expanding its global outreach, opening avenues for sales of research and clinical devices.

Expanding Market Presence Participation in key industry events including psychiatric, neuroscience, and mental health conferences underlines Magstim’s active engagement in market development, providing multiple opportunities for outreach to clinicians, hospitals, and research centers.

Growth Potential With revenue estimated between 1 and 10 million dollars and a dedicated development focus on innovative neurostimulation devices, Magstim presents an attractive growth and sales opportunity within specialized neurological and psychiatric treatment markets.